Short answer: The Basaglar label has no missed-dose instructions in the prescribing information, Patient Information or Instructions for Use. It says Basaglar is injected under the skin once daily, at any time of day but at the same time every day. Unlike Tresiba, it gives no rule for a late dose, so ask your prescriber or pharmacist what to do.
| Situation | What the label says |
|---|---|
| Schedule | Once daily, any time of day but the same time every day (2.2) |
| Missed-dose rule | None in the label |
| Forms | KwikPen and Tempo Pen, 100 units/mL (16.1) |
No. We checked the Basaglar prescribing information, Patient Information and both pens' Instructions for Use from Eli Lilly on DailyMed. None says what to do after a missed dose. Section 2.2: "Inject BASAGLAR subcutaneously once daily at any time of day but at the same time every day."
Basaglar, Lantus and Semglee are all insulin glargine 100 units/mL, but each has its own label. None of the three labels has a missed-dose rule. The Tresiba label is the one with a written rule for a late basal dose, and that rule belongs to Tresiba only.
This page summarizes FDA labeling. It is not personalized medical advice; confirm what to do with your prescriber or pharmacist.